Neil H. Segal, MD, PhD, discusses the current role of immunotherapy in colorectal cancer and the work being done to define its role in earlier-line settings and among patients with microsatellite stable disease.
Original Article: Research Efforts Poised to Redefine Role of Immunotherapy in mCRC